Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 11-1996 | 08-1996 | 05-1996 | 02-1996 | 11-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 60 | 527 | 0 | N/A | N/A |
| Depreciation Amortization | 309 | 1,293 | 0 | N/A | N/A |
| Other Working Capital | 590 | -2,392 | 0 | N/A | N/A |
| Other Operating Activity | 0 | 173 | 0 | 0 | 0 |
| Operating Cash Flow | $959 | $-399 | $0 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -197 | -2,567 | 0 | N/A | N/A |
| Investing Cash Flow | $-197 | $-2,567 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -22 | -67 | 0 | N/A | N/A |
| Other Financing Activity | -400 | 2,490 | 0 | 0 | 0 |
| Financing Cash Flow | $-422 | $2,423 | $0 | $N/A | $N/A |
| Beginning Cash Position | 632 | 632 | 0 | N/A | N/A |
| End Cash Position | 972 | 111 | 0 | N/A | N/A |
| Net Cash Flow | $340 | $-521 | $0 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 959 | -399 | 0 | N/A | N/A |
| Free Cash Flow | 959 | -399 | 0 | 0 | 0 |